Comparison of Levofloxacin- and Moxifloxacin-Based Triple Therapies with Standard Treatment in Eradication of Helicobacter Pylori as First-Line Therapy

Publisher： Karger

E-ISSN： 1421-9867|90|4|261-264

ISSN： 0012-2823

Source： Digestion, Vol.90, Iss.4, 2014-12, pp. : 261-264

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Is levofloxacin-based triple therapy an alternative for first-line eradication of Helicobacter pylori? A systematic review and meta-analysis

By Xiao Shu-Ping   Gu Min   Zhang Guo-Xin  

Scandinavian Journal of Gastroenterology, Vol. 49, Iss. 5, 2014-05 ,pp. : 528-538

Informa Healthcare

Access to resources Recommend Favorite

Safety and efficacy of 1-week levofloxacin-based triple therapy in first-line treatment for Helicobacter pylori -related peptic ulcer disease in Kashmir, India

By Shah Altaf  

Indian Journal of Gastroenterology, Vol. 32, Iss. 1, 2013-01 ,pp. : 32-36

Springer Publishing Company

Access to resources Recommend Favorite

Bismuth-Based First-Line Therapy for Helicobacter pylori Eradication in Type 2 Diabetes Mellitus Patients

By  

Digestion, Vol. 82, Iss. 1, 2010-03 ,pp. : 47-53

Karger

Access to resources Recommend Favorite

A New Second-Line Sequential Regimen for Helicobacter pylori Eradication Based on Levofloxacin: A Pilot Study

By Krystallis C.   Kamberoglou D.   Pistiolas D.   Anifanti C.   Koutsoumbas A.   Doulgeroglou V.   Tzias V.  

Digestive Diseases and Sciences, Vol. 55, Iss. 12, 2010-12 ,pp. : 3630-3631

Springer Publishing Company

Access to resources Recommend Favorite

Comparison of Proton Pump Inhibitor-Based Triple Therapy with Losec and the Generic Drug, Omepradex, for Efficacy of Helicobacter pylori Eradication

By Niv Yaron  

Digestive Diseases and Sciences, Vol. 50, Iss. 4, 2005-04 ,pp. : 623-625

Springer Publishing Company

Access to resources Recommend Favorite